Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer November 28, 2017October 21, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: Thermo Fisher Scientific & Pfizer Partner to…Roche announces U.S. collaboration with Pfizer to…Ad hoc announcement pursuant to Art. 53 LR Roche…[Ad hoc announcement pursuant to Art. 53 LR] Roche…[Ad hoc announcement pursuant to Art. 53 LR] Roche…Roche announces positive Phase III results for…
